In focus
Latest feed
Cipla Shares Poised for a Jump as Citi Flags Near‑Term US Growth Triggers
The Road Ahead for Semaglutide Generics: Why API Capacity Is the Real Game‑Changer, Says Goldman Sachs
Aurobindo Pharma Scores Major USFDA Win with Generic Tofacitinib Tablets
The Curious Case of Ozempic's Canadian Patent: A Legal Time Bomb?
